Asthma trials in Mexico
9 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With Asthma
- Where
- Guadalajara, Querétaro, San Juan del Río, Villahermosa
- Age
- 6 years to 11 years
- People
- 200 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT05562466 · EU 2022-501899-26-00 - Phase 3Taking peopleA Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
- Where
- Chihuahua City, Guadalajara, Mexico City, Veracruz
- Age
- 5 years to 11 years
- People
- 231 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06023589 - Phase 3Taking peopleEvaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
- Where
- Chihuahua City, Guadalajara, Monterrey
- Age
- 12 years to 17 years
- People
- 440 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06307665 - Phase 2Taking peopleA Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
- Where
- Aguascalientes, Chihuahua City, Durango, Guadalajara, Mérida, Morelia, Querétaro, Veracruz
- Age
- 18 years to 75 years
- People
- 531 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07219173 - No phaseTaking peopleAssess Accuracy of Primary Care Asthma and COPD Diagnosis Using Oscillometry and FeNO vs Specialist Diagnosis
- Where
- Monterrey, Santiago de Quer Taro
- Age
- 18 years and over
- People
- 600 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07245576 - Phase 2Taking peopleA Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma
- Where
- Apodaca, Guadalajara, San Juan
- Age
- 4 years to 11 years
- People
- 69 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07525375 · EU 2025-524914-26-00 - Phase 2Enrolling by invitationLong-term Safety and Efficacy Evaluation of Lunsekimig (SAR443765) in Adult Participants With Asthma
- Where
- Chihuahua City, Durango, Mérida, Monterrey, San Juan del Río, Veracruz
- Age
- 18 years and over
- People
- 900 worldwide
- Run by
- Sanofi
See details and how to joinNCT06609239 · EU 2025-522896-27-00 - Phase 3Enrolling by invitationEfficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS)
- Where
- Durango, San Juan del Río, Veracruz
- Age
- 2 years to 5 years
- People
- 90 worldwide
- Run by
- Sanofi
See details and how to joinNCT06191315 · EU 2023-504331-41-00 - Phase 2Taking peopleTherapeutic Equivalence of CHF5993 pMDI 100/6/12.5 µg HFA-152a in Subjects With Mild to Moderate Asthma
- Where
- Durango, Mérida, Mexico City
- Age
- 18 years to 75 years
- People
- 780 worldwide
- Run by
- Chiesi Farmaceutici S.p.A.
See details and how to joinNCT07301736 · EU 2025-521456-35-00